Drawing for VS XCITE

USPTO serial 79379182

VS XCITE

Reviewed by CopyMark Law Group

Reg. 7592526Status 700Registered
Filing date
Status date
Registration date
Dec 10, 2024
Examiner
BRADLEY, EVELYN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VS XCITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence J. Crain

Lawrence J. Crain Greer, Burns & Crain, Ltd.200 West MadisonSuite 2100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for scientific research, pharmaceutical research, clinical research and for industrial purposes namely, genetically modified cells and vectors for production of human, animal and synthetic proteinsACTIVE—
005Biological preparations for medical use, namely, genetically modified cells and genetically modified vectors for production of human, animal and synthetic proteins for medical, and clinical use in human and animal therapiesACTIVE—
040Custom manufacturing according to third-party orders and specifications of genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial use in scientific research and in pharmaceutical research, as well as for clinical and commercial use in human and animal therapiesACTIVE—
042Medical and scientific research in the field of protein expression; technical consultation and design in the field of protein expression research; scientific research and development in the field of protein expression; scientific research and development in the field of protein expression for third partiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 31, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 13, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 13, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 10, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 20, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 20, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 10, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 10, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 12, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 12, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2024RFNTREFUSAL PROCESSED BY IB—
Mar 20, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2024RFRRREFUSAL PROCESSED BY MPU—
Feb 29, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 28, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2024DOCKASSIGNED TO EXAMINER—
Sep 29, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 25, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 21, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance